Cargando…

Therapeutic Potential of Epigallocatechin Gallate Nanodelivery Systems

Nowadays, the society is facing a large health problem with the rising of new diseases, including cancer, heart diseases, diabetes, neurodegenerative diseases, and obesity. Thus, it is important to invest in substances that enhance the health of the population. In this context, epigallocatechin gall...

Descripción completa

Detalles Bibliográficos
Autores principales:	Granja, Andreia, Frias, Iúri, Neves, Ana Rute, Pinheiro, Marina, Reis, Salette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5534279/ https://www.ncbi.nlm.nih.gov/pubmed/28791306 http://dx.doi.org/10.1155/2017/5813793

Ejemplares similares

Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy
por: Granja, Andreia, et al.
Publicado: (2016)

Design, development, and characterization of lipid nanocarriers-based epigallocatechin gallate delivery system for preventive and therapeutic supplementation
por: Frias, Iúri, et al.
Publicado: (2016)

Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability
por: Neves, Ana Rute, et al.
Publicado: (2013)

EGCG intestinal absorption and oral bioavailability enhancement using folic acid-functionalized nanostructured lipid carriers
por: Granja, Andreia, et al.
Publicado: (2019)

Epigallocatechin-3-gallate Delivered in Nanoparticles Increases Cytotoxicity in Three Breast Carcinoma Cell Lines
por: Farabegoli, Fulvia, et al.
Publicado: (2022)

Food-Grade Encapsulation Systems for (−)-Epigallocatechin Gallate
por: Shi, Meng, et al.
Publicado: (2018)

Epigallocatechin-3-Gallate Therapeutic Potential in Cancer: Mechanism of Action and Clinical Implications
por: Kciuk, Mateusz, et al.
Publicado: (2023)

Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)
por: Singh, Neha Atulkumar, et al.
Publicado: (2016)

Epigallocatechin-3-Gallate Delivery in Lipid-Based Nanoparticles: Potentiality and Perspectives for Future Applications in Cancer Chemoprevention and Therapy
por: Farabegoli, Fulvia, et al.
Publicado: (2022)

The Potential Role of Epigallocatechin-3-Gallate (EGCG) in Breast Cancer Treatment
por: Marín, Víctor, et al.
Publicado: (2023)

Nanodelivery of Dietary Polyphenols for Therapeutic Applications
por: Rudrapal, Mithun, et al.
Publicado: (2022)

Risk Assessment of Caffeine and Epigallocatechin Gallate in Coffee Leaf Tea
por: Tritsch, Nadine, et al.
Publicado: (2022)

The potential of epigallocatechin gallate in the chemoprevention and therapy of hepatocellular carcinoma
por: Li, Dongming, et al.
Publicado: (2023)

Exploring the Potential of Cannabinoid Nanodelivery Systems for CNS Disorders
por: Kolesarova, Mariana, et al.
Publicado: (2023)

Inhibitory Effects of (−)-Epigallocatechin-3-gallate on Esophageal Cancer
por: Wang, Liu-Xiang, et al.
Publicado: (2019)

Preclinical Activities of Epigallocatechin Gallate in Signaling Pathways in Cancer
por: Sharifi-Rad, Mehdi, et al.
Publicado: (2020)

Skin Protective Effect of Epigallocatechin Gallate
por: Kim, Eunji, et al.
Publicado: (2018)

Role of Epigallocatechin Gallate in Glucose, Lipid, and Protein Metabolism and L-Theanine in the Metabolism-Regulatory Effects of Epigallocatechin Gallate
por: Lin, Ling, et al.
Publicado: (2021)

Anticancer effects and molecular mechanisms of epigallocatechin-3-gallate
por: Min, Kyoung-jin, et al.
Publicado: (2014)

Prooxidant Effects of Epigallocatechin-3-Gallate in Health Benefits and Potential Adverse Effect
por: Ouyang, Jie, et al.
Publicado: (2020)

Potential benefit of (-)-epigallocatechin-3-gallate for macrovascular complications in diabetes
por: Tang, L., et al.
Publicado: (2017)

Reducing the potential allergenicity of amandin through binding to (−)-epigallocatechin gallate
por: Luo, Xin, et al.
Publicado: (2022)

Potential Biological Effects of (‐)‐Epigallocatechin‐3‐gallate on the Treatment of Nonalcoholic Fatty Liver Disease
por: Chen, Cheng, et al.
Publicado: (2017)

The Potential Roles of Epigallocatechin-3-Gallate in the Treatment of Ovarian Cancer: Current State of Knowledge
por: Bimonte, Sabrina, et al.
Publicado: (2020)

The Potential of Epigallocatechin Gallate (EGCG) in Targeting Autophagy for Cancer Treatment: A Narrative Review
por: Ferrari, Elena, et al.
Publicado: (2022)

Epigallocatechin-3-Gallate (EGCG): New Therapeutic Perspectives for Neuroprotection, Aging, and Neuroinflammation for the Modern Age
por: Payne, Ashley, et al.
Publicado: (2022)

Epigallocatechin-3-gallate and cancer: focus on the role of microRNAs
por: Wang, Chunguang, et al.
Publicado: (2023)

Food-Grade Microencapsulation Systems to Improve Protection of the Epigallocatechin Gallate
por: Ralaivao, Mathis, et al.
Publicado: (2022)

Effect of Epigallocatechin Gallate on Viability of Kudoa septempunctata
por: Shin, Sang Phil, et al.
Publicado: (2020)

Green Tea Extracts Epigallocatechin-3-gallate for Different Treatments
por: Chu, Chenyu, et al.
Publicado: (2017)

Effects of epigallocatechin-3-gallate combined with ascorbic acid and glycerol on the stability and uric acid-lowering activity of epigallocatechin-3-gallate
por: Xie, Qianjin, et al.
Publicado: (2021)

Potential of Cucurbitacin B and Epigallocatechin Gallate as Biopesticides against Aphis gossypii
por: Zhao, Chenchen, et al.
Publicado: (2021)

A combination of metformin and epigallocatechin gallate potentiates glioma chemotherapy in vivo
por: Kuduvalli, Shreyas S., et al.
Publicado: (2023)

Nanoparticles in life sciences and biomedicine
por: Rute Neves, Ana, et al.
Publicado: (2018)

Green tea polyphenol epigallocatechin 3-gallate in arthritis: progress and promise
por: Ahmed, Salahuddin
Publicado: (2010)

Function of Green Tea Catechins in the Brain: Epigallocatechin Gallate and its Metabolites
por: Pervin, Monira, et al.
Publicado: (2019)

Advances in the Antagonism of Epigallocatechin-3-gallate in the Treatment of Digestive Tract Tumors
por: Liu, Changwei, et al.
Publicado: (2019)

Protective Effects of Epigallocatechin Gallate (EGCG) on Endometrial, Breast, and Ovarian Cancers
por: Huang, Yun-Ju, et al.
Publicado: (2020)

Epigallocatechin-3-gallate and Epigallocatechin-3-O-(3-O-methyl)-gallate Enhance the Bonding Stability of an Etch-and-Rinse Adhesive to Dentin
por: Yu, Hao-Han, et al.
Publicado: (2017)

EGCG Mediated Targeting of Deregulated Signaling Pathways and Non-Coding RNAs in Different Cancers: Focus on JAK/STAT, Wnt/β-Catenin, TGF/SMAD, NOTCH, SHH/GLI, and TRAIL Mediated Signaling Pathways
por: Farooqi, Ammad Ahmad, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_291hqa4q2henaojme63rmrp3mu